10% Cost 1,631 1,509 Gross profit 209 164 45 28% Gross profit margin 11.3% 9.8% Other income 6 2 4 246% Selling & Admin expenses 123 121 2 2% 6.7% 7.2% Cost and expense from delayed project 57 (57
Expenses 94.81 174.68 196.77 Selling Expense (18.34) (29.70) (34.16) Administrative Expense (55.25) (66.00) (60.45) Total Expenses (73.59) (95.70) (94.61) Earnings before Finance Costs 21.22 78.98 102.16
) (2,267) (100%) Profit (Loss) before the effects of foreign exchange, deferred income tax and lease income 20,507 8,702 246 214 20,753 8,916 11,837 100% Deferred income (expense) tax (23) 346 2 (1) (21) 345
, net foreign exchange gain (loss) has taken into account fair value valuation of derivatives in accordance with TFRS9. 3. Adjusted Net Income is net profit attributed to the Company excluding "fair value
financing costs and income tax expense 261.30 26.17 34.53 14.26 267.19 26.66 37.76 15.55 226.77 656.73 Financing cost 3.15 0.32 11.22 4.63 6.55 0.65 10.05 4.14 (8.07) (71.93) Profit before income tax expense
true earnings from its normal operations. In Q1/2020, such amortization expense adds up to Baht 368 million consisting of the amortization of assets acquired from the acquisition of GLOW amounting Baht
the employee benefits obligations approximately Baht 5.90 million. These were divided into two sections 1). cost of hospital operations in amounts of Baht 3.78 million. selling expense in amounts of
expenses, and other selling expenses such as marketing and promotional expenses, and depreciation of asset in each branch. In Quarter 1/ 2019 and Quarter 1/2018, the Company incurred selling expense totaling
% Administrative expenses (26.21) (39.92) (13.71) 52.31% Share of profit of investments in associate 0.09 0.13 0.04 46.78% Finance costs (0.26) (0.34) (0.07) 28.01% Profit before income tax expense 86.37 113.36
) 13.82% Administrative expenses (11.29) (7.77) 3.51 -31.13% Share of gain of investments in associate 0.03 0.03 0.00 0.25% Finance costs (0.08) (0.06) 0.02 -22.49% Profit before income tax expense 30.31